Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial.

PubWeight™: 3.07‹?› | Rank: Top 1%

🔗 View Article (PMID 15069048)

Published in JAMA on April 07, 2004

Authors

Robert W Taylor1, Janice L Zimmerman, R Phillip Dellinger, Richard C Straube, Gerard J Criner, Kenneth Davis, Kathleen M Kelly, Thomas C Smith, Robert J Small, Inhaled Nitric Oxide in ARDS Study Group

Author Affiliations

1: Critical Care Medicine, St Louis University/St John's Mercy Medical Center, St Louis, Mo, USA.

Articles citing this

The acute respiratory distress syndrome. J Clin Invest (2012) 5.61

Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med (2009) 3.75

Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med (2005) 3.69

Effect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trial. JAMA (2005) 3.21

Nonventilatory treatments for acute lung injury and ARDS. Chest (2007) 3.02

Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med (2006) 2.47

Therapeutic strategies for severe acute lung injury. Crit Care Med (2010) 2.12

Pulmonary vascular dysfunction is associated with poor outcomes in patients with acute lung injury. Am J Respir Crit Care Med (2010) 2.01

Concern Protection from lipopolysaccharide-induced lung injury by augmentation of airway S-nitrosothiols. Am J Respir Crit Care Med (2009) 1.74

Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med (2008) 1.61

Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure. Chest (2009) 1.28

Assessment and treatment of right ventricular failure. Nat Rev Cardiol (2013) 1.22

Acute respiratory distress syndrome: new definition, current and future therapeutic options. J Thorac Dis (2013) 1.19

Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care (2010) 1.18

Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)). Ger Med Sci (2010) 1.13

Clinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome - hope or hype? Crit Care (2012) 1.04

Acute respiratory distress syndrome: A clinical review. Pulm Circ (2011) 1.02

Acute respiratory distress syndrome: pathophysiology and therapeutic options. J Clin Med Res (2012) 1.01

Pathophysiology, management and treatment of smoke inhalation injury. Expert Rev Respir Med (2009) 1.00

Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase. J Immunol (2012) 0.97

Fluid management in acute lung injury and ards. Ann Intensive Care (2011) 0.92

Pathophysiology of pulmonary hypertension in acute lung injury. Am J Physiol Lung Cell Mol Physiol (2012) 0.92

Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale. Med Hypotheses (2011) 0.89

Therapeutic effect of intravenous infusion of perfluorocarbon emulsion on LPS-induced acute lung injury in rats. PLoS One (2014) 0.89

Immunoregulatory and antimicrobial effects of nitrogen oxides. Proc Am Thorac Soc (2006) 0.89

Bench-to-bedside review: Inhaled nitric oxide therapy in adults. Crit Care (2009) 0.89

[Diagnosis and therapy of sepsis]. Clin Res Cardiol (2006) 0.87

Improvements in pulmonary and general critical care reduces mortality following ventilator-associated pneumonia. J Trauma Acute Care Surg (2013) 0.87

Arterial pulmonary hypertension in noncardiac intensive care unit. Vasc Health Risk Manag (2008) 0.86

Management of acute right ventricular failure in the intensive care unit. Ann Am Thorac Soc (2014) 0.86

Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension. Nitric Oxide (2012) 0.85

Year in review in Intensive Care Medicine 2012: I. Neurology and neurointensive care, epidemiology and nephrology, biomarkers and inflammation, nutrition, experimentals. Intensive Care Med (2012) 0.84

The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysis. Chest (2015) 0.84

Inhaled nitric oxide therapy and risk of renal dysfunction: a systematic review and meta-analysis of randomized trials. Crit Care (2015) 0.84

Critical care trial design and interpretation: a primer. Crit Care Med (2010) 0.83

Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS. Br J Pharmacol (2015) 0.83

Sepsis and Acute Respiratory Distress Syndrome: Recent Update. Tuberc Respir Dis (Seoul) (2016) 0.83

Inhaled nitric oxide and the risk of renal dysfunction in patients with acute respiratory distress syndrome: a propensity-matched cohort study. Crit Care (2016) 0.81

Protein-based therapies for acute lung injury: targeting neutrophil extracellular traps. Expert Opin Ther Targets (2014) 0.81

A broken heart: right-to-left shunt in the setting of normal cardiac pressures. Can J Cardiol (2008) 0.81

Failure to Improve the Oxygenation Index Is a Useful Predictor of Therapy Failure in Acute Respiratory Distress Syndrome Clinical Trials. Crit Care Med (2016) 0.79

Performance of Multiple Risk Assessment Tools to Predict Mortality for Adult Respiratory Distress Syndrome with Extracorporeal Membrane Oxygenation Therapy: An External Validation Study Based on Chinese Single-center Data. Chin Med J (Engl) (2016) 0.79

Albumin and furosemide for acute lung injury. Crit Care (2007) 0.78

Association between inhaled nitric oxide treatment and long-term pulmonary function in survivors of acute respiratory distress syndrome. Crit Care (2012) 0.78

Pharmacological interventions in acute respiratory distress syndrome. Ann Intensive Care (2013) 0.77

Association between inflammatory mediators and response to inhaled nitric oxide in a model of endotoxin-induced lung injury. Crit Care (2008) 0.77

Corticosteroids and ARDS: A review of treatment and prevention evidence. Lung India (2011) 0.77

Inhaled nitric oxide for acute lung injury: no place for NO? JAMA (2004) 0.75

Inhaled nitric oxide in acute lung injury. JAMA (2004) 0.75

Clinical Practice Guideline of Acute Respiratory Distress Syndrome. Tuberc Respir Dis (Seoul) (2016) 0.75

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Intensive care management of pulmonary hypertension. Ann Thorac Med (2014) 0.75

Acute respiratory distress syndrome. BMJ Clin Evid (2007) 0.75

Stimulators of soluble guanylyl cyclase: future clinical indications. Ochsner J (2013) 0.75

Inhaled nitric oxide alleviates hyperoxia suppressed phosphatidylcholine synthesis in endotoxin-induced injury in mature rat lungs. Respir Res (2006) 0.75

What is the clinical significance of pulmonary hypertension in acute respiratory distress syndrome? A review. Minerva Anestesiol (2013) 0.75

Management of refractory hypoxemia. Ann Card Anaesth (2016) 0.75

The evaluation and management of thermal injuries: 2014 update. Clin Exp Emerg Med (2014) 0.75

The clinical practice guideline for the management of ARDS in Japan. J Intensive Care (2017) 0.75

Mesenchymal stromal cells for treatment of the acute respiratory distress syndrome: The beginning of the story. J Intensive Care Soc (2015) 0.75

Zinc Chloride Smoke Inhalation Induced Severe Acute Respiratory Distress Syndrome: First Survival in the United States with Extended Duration (Five Weeks) Therapy with High Dose Corticosteroids in Combination with Lung Protective Ventilation. Case Rep Crit Care (2017) 0.75

Successful treatment of acute respiratory distress syndrome after hysterectomy for life-threatening atonic bleeding by inhaled nitric oxide. J Anesth (2011) 0.75

[Acute respiratory distress syndrome : Basic principles and treatment]. Anaesthesist (2017) 0.75

Articles by these authors

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med (2004) 24.47

Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33

The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med (2010) 6.69

A randomized study of endobronchial valves for advanced emphysema. N Engl J Med (2010) 6.23

Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2010) 6.01

Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med (2014) 5.70

Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest (2006) 5.31

The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med (2010) 4.64

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med (2004) 4.56

Impact of delayed transfer of critically ill patients from the emergency department to the intensive care unit. Crit Care Med (2007) 4.54

Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis. Crit Care Med (2014) 4.11

Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis (2012) 4.07

A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med (2016) 3.99

Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med (2015) 3.55

Rhabdomyolysis. Chest (2013) 3.48

Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med (2006) 3.36

Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology (2011) 3.30

The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*. Crit Care Med (2014) 3.17

Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med (2015) 2.81

Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med (2007) 2.77

Critical care medicine training and certification for emergency physicians. Ann Emerg Med (2005) 2.67

Relationship between supranormal oxygen tension and outcome after resuscitation from cardiac arrest. Circulation (2011) 2.65

Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock (2009) 2.59

Point: Are the best patient outcomes achieved when ICU bundles are rigorously adhered to? Yes. Chest (2013) 2.59

Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg (2006) 2.53

An international survey: Public awareness and perception of sepsis. Crit Care Med (2009) 2.40

Activated protein C and septic shock: a propensity-matched cohort study*. Crit Care Med (2012) 2.39

Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 2.32

Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 2.20

Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis (2004) 2.17

Part 8: Post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2015) 2.16

Critical care medicine training and certification for emergency physicians. Crit Care Med (2005) 2.12

A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD (2012) 2.07

Optimal temperature for malaria transmission is dramatically lower than previously predicted. Ecol Lett (2012) 2.07

Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04

Are nurse injectors the new norm? Aesthetic Plast Surg (2014) 2.03

Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med (2003) 2.03

Transfusion of packed red blood cells is not associated with improved central venous oxygen saturation or organ function in patients with septic shock. J Emerg Med (2012) 2.02

Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med (2004) 1.96

Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med (2007) 1.88

African Americans' participation in clinical research: importance, barriers, and solutions. Am J Surg (2007) 1.88

CT metrics of airway disease and emphysema in severe COPD. Chest (2009) 1.81

Treatment of persistent pulmonary air leaks using endobronchial valves. Chest (2009) 1.75

Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration (2014) 1.74

Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study. Crit Care Med (2014) 1.72

Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. Am J Respir Crit Care Med (2014) 1.68

Strategies for improving survival after in-hospital cardiac arrest in the United States: 2013 consensus recommendations: a consensus statement from the American Heart Association. Circulation (2013) 1.67

Respiratory failure after lung transplantation. Chest (2003) 1.67

Racial differences in quality of life in patients with COPD. Chest (2011) 1.64

An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63

New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 1.59

Lung volume reduction therapies for advanced emphysema: an update. Chest (2010) 1.58

A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis. Crit Care Med (2013) 1.58

Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-α fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double-blind, placebo-controlled phase IIb study*. Crit Care Med (2014) 1.56

Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene. Am J Hum Genet (2009) 1.52

Pulmonary diseases and the heart. Circulation (2007) 1.52

A qualitative study exploring moral distress in the ICU team: the importance of unit functionality and intrateam dynamics. Crit Care Med (2015) 1.51

African Americans and men with severe COPD have a high prevalence of osteoporosis. COPD (2008) 1.49

Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg (2005) 1.46

Use of a standardized order set for achieving target temperature in the implementation of therapeutic hypothermia after cardiac arrest: a feasibility study. Acad Emerg Med (2008) 1.46

Sepsis severity score: an internationally derived scoring system from the surviving sepsis campaign database*. Crit Care Med (2014) 1.46

Looks good but feels bad: factors that contribute to poor results after total knee arthroplasty. J Arthroplasty (2007) 1.45

Weight gain after lung reduction surgery is related to improved lung function and ventilatory efficiency. Am J Respir Crit Care Med (2012) 1.43

Randomized controlled trial of inhaled nitric oxide for the treatment of microcirculatory dysfunction in patients with sepsis*. Crit Care Med (2014) 1.42

Drotrecogin alfa (activated) in an infant with gram-negative septic shock. J Intensive Care Med (2004) 1.42

Treatment of Guillain-Barré syndrome induced by cyclosporine in a lung transplant patient. J Heart Lung Transplant (2005) 1.42

Inhaled nitric oxide: should it be used in acute respiratory distress syndrome? Crit Care Med (2006) 1.39

Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Intensive Care Med (2014) 1.38

Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA. J Infect Dis (2010) 1.37

Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med (2009) 1.36

Smoking patterns in African Americans and whites with advanced COPD. Chest (2004) 1.33

Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.29

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. J Trauma (2008) 1.26

Advanced emphysema in African-American and white patients: do differences exist? Chest (2006) 1.24

Impact of whole-body rehabilitation in patients receiving chronic mechanical ventilation. Crit Care Med (2005) 1.23

Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis (2007) 1.23

Total knee arthroplasty has higher postoperative morbidity than unicompartmental knee arthroplasty: a multicenter analysis. J Arthroplasty (2012) 1.23

Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 1.21

Transfusion practice and blood stream infections in critically ill patients. Chest (2005) 1.19

Red blood cell transfusion and ventilator-associated pneumonia: A potential link? Crit Care Med (2004) 1.15

Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest (2014) 1.15

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med (2017) 1.15

Automated telecommunication to obtain longitudinal follow-up in a multicenter cross-sectional COPD study. COPD (2012) 1.15

Fluid resuscitation influences cardiovascular performance and mortality in a murine model of sepsis. Intensive Care Med (2008) 1.14

Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study. Respir Res (2014) 1.14

Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction. Biol Psychiatry (2007) 1.12

The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial. Trials (2014) 1.12

Small airway pathology and bronchoreversibility in advanced emphysema. COPD (2010) 1.11

Infections and severe sepsis in solid-organ transplant patients admitted from a university-based ED. Am J Emerg Med (2004) 1.10

Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation. Respir Res (2010) 1.10

Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophr Res (2003) 1.06

Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain. Pain (2013) 1.05

Aging Phenotypes of Common Marmosets (Callithrix jacchus). J Aging Res (2012) 1.04

Small airway mucous metaplasia and inflammation in chronic obstructive pulmonary disease. COPD (2008) 1.03

Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema--potential mechanisms, treatment algorithm, and case examples. Respiration (2014) 1.03

Intralobar sequestration in the middle-aged and elderly adult: recognition and radiographic evaluation. J Thorac Cardiovasc Surg (2003) 1.02